Amplification status of GAS41 and MDM2 in adenocarcinomas

腺癌中 GAS41 和 MDM2 的扩增状态

• 批准号: 201557
• 负责人: Pikor Larissa
• 金额: $ 1.27万
• 依托单位: BC Cancer, part of PHSA (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-02-01 至 2011-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=201557&lang=en
• 关键词: 12q13-15; Co-Amplification; Gas41; Gene Expression; Lung Cancer; Mdm2; P53; Tumorigenesis

Lung cancer is the number one cause of cancer death worldwide. High mortality rates are attributed to poor therapeutic strategies and a lack of screening for early detection. A greater understanding of lung cancer biology is therefore needed to identify

肺癌是全球癌症死亡的头号原因。高死亡率是由于治疗策略不佳和缺乏早期发现的筛查。因此，需要对肺癌生物学有更深入的了解